This study evaluates whether a digital patient education program can improve adherence to KDIGO 2022 dietary recommendations (low sodium and optimal protein intake) among patients with type 2 diabetes and chronic kidney disease (eGFR 30-59 ml/min).
Type 2 diabetes (ICD-10 DE11.x)
Age 18-74 years
BMI < 35 kg/m²
eGFR 30-59 ml/min and UACR > 30 mg/g
Type 1 diabetes or other diabetes types
Current vegan diet
Active cancer
Short bowel syndrome or celiac disease
Single group
StenoFood App
DeviceDigital patient education program (app-based) with dietary guidance and self-monitoring tools
Change in sodium excretion between measurements at baseline and 6 months follow-up
Sodium intake (g/day) will be estimated by the average of 2 collections of 24-hour urinary sodium at both baseline and follow-up
Change in protein intake (g/kg/day) between baseline and follow-up measurements
Protein intake will be estimated from the average of 2 collections of 24 hour urinary urea nitrogen at both baseline and follow-up
Change in Blood pressure between baseline and follow-up
average of the two last blood preassure measurements out of three
Change in albumin, potassium and phosphate excretion between baseline and follow-up
biochemical analysis of albumin, potassium, phosphate excreted in 2\* 24 hour urine collections at baseline and follow-up
Change in dietary patterns between baseline and follow-up
at both baseline and follow-up participants will fill in a three day food record as well as screeners for salt and protein intake
Changes between baseline and follow-up in blood lipids
At both baseline and follow-up participants and controls will have blood samples taken for biochemical analyses of blood lipids
Change in selfreported health, motivation, self efficcacy, food and healthy literacy baseline and follow-up
at both baseline and follow-up participants will answer questionnaires on food literacy, health literacy, selfperceived health, motivation, selfefficacy and health literacy
Salt intake measured by spot-urine dipstick measurements
Feasibility study of dipstick measurements for self-monitoring of saltintake based on two morning and one evening measurements by the Quantab chloride dipsticks
Click on the lead sponsor to view all of their trials.
